OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Therapeutic drug monitoring
Pharmacogenetic and Pharmacogenomics
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Change patient management
Observational
403 Publications
found
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.
b
BMC medicine
February 1, 2022
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Safety
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
b
Cancer discovery
February 1, 2022
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?
b
Inflammatory intestinal diseases
January 1, 2022
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Economics
Observational
Operational efficiencies
Patient-centeredness
The Follow-Up of Chinese Patients in cblC Type Methylmalonic Acidemia Identified Through Expanded Newborn Screening.
b
Frontiers in genetics
January 1, 2022
p
Newborn Screening
c
Change patient management
Clinical outcomes
Observational
Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program.
b
Translational oncology
January 1, 2022
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine.
b
JCO precision oncology
January 1, 2022
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Multi-omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.
b
Molecular oncology
January 1, 2022
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Real-World Analysis of Off-Label Use of Molecularly Targeted Therapy in a Large Academic Medical Center Cohort.
b
JCO precision oncology
January 1, 2022
p
Cancer
c
Change patient management
Clinical outcomes
Observational
EGFR-mutation testing and TKI treatment patterns in locally advanced and metastatic NSCLC in Norway – A nationwide retrospective cohort study.
b
Cancer treatment and research communications
January 1, 2022
p
Cancer
c
Change patient management
Observational
Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real world.
b
Cancer medicine
January 1, 2022
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Previous Page
1
…
8
9
10
11
12
…
41
Next Page